New hope for advanced cancers: first human trial of ERX-315 begins
NCT ID NCT06533332
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 31 times
Summary
This early-stage study tests a new drug called ERX-315 in people with advanced solid tumors (like breast, ovarian, or pancreatic cancer) that no longer respond to standard treatments. The main goal is to check the drug's safety and find the best dose for future studies. About 15 participants will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Research SA
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Icon Cancer Centre Adelaide
RECRUITINGAdelaide, South Australia, 5037, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Macquarie University Health
RECRUITINGRyde, New South Wales, 2109, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Kinghorn Cancer Center
RECRUITINGSydney, New South Wales, 2010, Australia
Conditions
Explore the condition pages connected to this study.